BaseLaunch is now accepting applications
BaseLaunch helps build therapeutic ventures to the point where they can raise a Series-A financing round or similar.
Are you developing novel therapeutics, or novel therapeutic platforms? We are looking for highly innovative pharma-biotech projects to support. One major thing we provide to help get companies there is funding – up to USD $ 500,000 per venture. Learn more at www.baselaunch.ch
Share this article
You may also be interested in
Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed by an Interpharma report. However, the region also shines in an international comparison. Interpharma CEO René Buholzer regards it as “probably the most productive life sciences location in the world”.Read More
Resistell AG, based in Muttenz in the canton of Basel-Landschaft, has received a grant of up to 2.5 million euros and additional equity capital financing from a European fund with the aim of accelerating innovation. The company is developing the world’s fastest test against antibiotic resistance.Read More
Startup Academy is on the road to success ten years after being founded. The initiative has supported 280 startups to date. The project was originally started in Basel and is now represented at several locations in Switzerland with plans for further growth.Read More